James C. Czirr is Director at GALECTIN THERAPEUTICS INC (GALT). They have made 14 open-market trades across 2 companies since 2006, most recently 2025-12-16.
CIK 0001260641
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $29K since 2012, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GALT | 5,614,457 | $20.4M |
| PRW | 4,222,268 | — |
| PRWP | 173,232 | — |
| PRWP.OB | 3,597,268 | — |
| Total | $20.4M |
Shares reported on the most recent Form 4, priced at the 2025-12-18 close. 3 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALT | SELL | 2025-12-16 | 2025-12-18 | $6.66 | $409K | -10.3% | -35.6% | -39.3% |
| GALT | SELL | 2024-04-22 | 2024-04-25 | $3.06 | $142K | -5.9% | -20.8% | -27.5% |
| GALT | SELL · 10b5-1 | 2022-07-22 | 2022-08-09 | $2.09 | $21K | +2.6% | -4.1% | -32.8% |
| GALT | SELL · 10b5-1 | 2021-08-02 | 2021-08-03 | $3.25 | $33K | +14.2% | +36.5% | +10.5% |
| GALT | SELL · 10b5-1 | 2021-04-22 | 2021-05-04 | $3.97 | $109K | +5.8% | +1.0% | -20.8% |
| GALT | SELL · 10b5-1 | 2021-04-01 | 2021-04-05 | $2.16 | $22K | +7.7% | +90.8% | +40.1% |
| GALT | SELL | 2018-06-14 | 2018-06-20 | $8.50 | $1.7M | -18.1% | -29.8% | -24.8% |
| GALT | SELL | 2018-06-13 | 2018-06-14 | $7.27 | $1.7M | -21.8% | -24.2% | -32.5% |
| GALT | SELL | 2018-06-08 | 2018-06-14 | $5.88 | $647K | -21.8% | -24.2% | -32.5% |
| GALT | SELL | 2018-06-01 | 2018-06-05 | $5.12 | $471K | +72.9% | +37.0% | +29.2% |
| GALT | SELL | 2018-01-25 | 2018-01-29 | $5.44 | $2.4M | -10.9% | -15.6% | -31.6% |
| GALT | SELL | 2016-04-20 | 2016-04-21 | $1.59 | $18K | -14.7% | -1.9% | -3.8% |
| GALT | SELL | 2016-04-19 | 2016-11-18 | $1.65 | $73K | -10.4% | -8.3% | +53.1% |
| GALT | SELL | 2014-01-10 | 2014-01-14 | $14.84 | $1.5M | -20.0% | +1.3% | +1.3% |
| GALT | BUY | 2013-11-15 | 2013-11-18 | $6.90 | $7K | -20.0% | +1.3% | +1.3% |
| GALT | SELL | 2013-10-07 | 2013-10-09 | $11.85 | $1.3M | -20.0% | +1.3% | +1.3% |
| GALT | BUY | 2012-05-17 | 2012-05-18 | $2.25 | $23K | -20.0% | +1.3% | +1.3% |
| PRWP.OB | SELL | 2009-01-21 | 2009-02-25 | $0.08 | $20K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-07-10 | 2006-07-11 | $3.00 | $15K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-07-07 | 2006-07-11 | $2.65 | $27K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-06-12 | 2006-06-13 | $3.25 | $65K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-06-01 | 2006-06-05 | $3.22 | $64K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-05-02 | 2006-05-04 | $3.28 | $66K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-04-03 | 2006-04-05 | $3.93 | $79K | N/A | N/A | N/A |
| PRW | SELL · 10b5-1 | 2006-02-28 | 2006-03-02 | $3.30 | $132K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.